Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment, and home care.
Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.
Headquartered in the Netherlands, Philips' health technology portfolio generated 2015 sales of EUR 16.8 billion and employs approximately 69,000 employees with sales and services in more than 100 countries.
Priorities as a partner of the Global Partnership for Sustainable Development Data
Philips aims to improve the lives of 2 billion people a year by 2020 and have 95% of Philips revenue aligned with the SDGs.
In emerging markets, through the use of IT and digital technologies available today, entire healthcare systems can leapfrog. One of the most important challenges for scaling such innovations is measuring the results of interventions. There is an urgent need for accurate, measurable data that enables measurement of health outcomes.
We are committed to developing digital innovations to accelerate a data-driven transformation of health care systems and deliver Universal Health Coverage.